To determine the mechanisms involved in the antitumor activity observed in response to the Id1-loss in combination with the blockade of PD-1/PD-L1 axis, we evaluated the changes induced in the tumor microenvironment by the combined blockade. Here, CD274 is linked to neoplasm.